TABLE 1.
Patient characteristics at admission.
| Parameters | Data |
|---|---|
| Male, n (%) | 20 (69.0%) |
| Mean age, years | 58.1 ± 10.6 |
| Lesion types | |
| Right lobe | 14 (48.3%) |
| Left lobe | 1 (3.4%) |
| Bi-lobar | 14 (48.3%) |
| Symptom duration, months | 1.0 (0.4, 10.5) |
| Recurrence after surgery | 5 (17.2%) |
| Systemic treatments | 21 (72.4%) |
| Targeted therapy | 9 (31.0%) |
| Immunotherapy | 2 (6.9%) |
| Targeted and immunotherapy | 10 (34.5%) |
| Hepatitis B virus infection | 14 (48.3%) |
| BCLC stage B/C | 8 (27.6%)/21 (72.4%) |
| Child–Pugh class A/B | 20 (69.0%)/9 (31.0%) |
| Multinodular/bulky tumor/diffuse | 5 (17.2%)/11 (37.9%)/13 (44.8%) |
| Portal vein trunk or IVC invasion | 5 (17.2%) |
| Portal vein or hepatic vein branch invasion | 7 (24.1%) |
| Extrahepatic sites | 13 (44.8%) |
| Lung | 2 (6.9%) |
| Lymph node | 10 (34.5%) |
| Bone | 2 (6.9%) |
| Spleen | 1 (3.4%) |
| Tumor diameter, mm | 91.6 ± 41.2 |
| a-Fetoprotein level | 24 (82.8%) |
| Normal | 7 (24.1%) |
| <400 ng/ml | 4 (13.8%) |
| 400–10,000 ng/ml | 8 (27.6%) |
| >10,000 ng/ml | 5 (17.2%) |
IVC = Inferior vena cava.